J Hematol

Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access

Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc

Journal website http://www.thejh.org

Original Article

Volume 7, Number 1, January 2018, pages 1-6

Alterations of Hematological Parameters, Hemoglobin and Hematocrit With Liver Enzymes, Aspartate Transaminase and Alanine Transaminase Among Patients With Chronic Kidney Disease Undergoing Hemodialysis in Aljouf Region, Saudi Arabia

Figures

Figure 1. Hemoglobin and hematocrit level in study population.

Figure 2. ALT and AST among study population.

Table

**Table 1.** Results of Hb, Hematocrit, ALT and AST of the First and Second Month of Patients With CKD Undergoing Hemodialysis Versus Healthy Individuals
Parameters	Participants	M (SD)	SEM
Statistical significance is shown in superscript parenthesis and determined by comparison of each parameter of patients with CKD undergoing HD with corresponding parameter of the healthy individuals. ^a: < 0.05; ^b > 0.05.
Hemoglobin, g/dL	Control	15.1 (1.8)	0.1
	First month	10.2 (0.7)^b	0.05
	Second month	8.9 (1.02)^a	0.08
Hematocrit, %	Control	44.6 (3.3)^b	0.2
	First month	27.2 (4.1)^b	0.3
	Second month	24.8 (2.6)^a	0.2
ALT, IU/L	Control	28.3 (5.3)	0.1
	First month	17.8 (1.1)^b	0.09
	Second month	15.6 (0.7)^a	0.06
AST, IU/L	Control	23.0 (2.2)	0.2
	First month	13.9 (1.1)^b	0.09
	Second month	12.0 (1.3)^a	0.11
Total	Control	171
	First month Second month	159 for each